# Verixa High-ROI Event Research: New Pharma AI/QMS Events (July 2026–July 2027)

## Priority ranking table

| Rank | Event | Date / location | ROI tier | Best Verixa posture | CFP / access timing | Why this is high ROI | Source |
|---:|---|---|---|---|---|---|---|
| 1 | PDA/FDA Joint Regulatory Conference 2026 | Sept. 14–16, 2026, Washington, DC | HIGH | Private meetings + targeted panel pitch if agenda slots remain | Speaker agenda appears largely set; sponsorship/exhibit open, but Verixa should avoid booth before Sept. | Direct FDA/PDA regulatory audience, CGMP/PQS/data governance agenda, and explicit AI regulatory-oversight content; strongest US QA/RA fit. | [PDA](https://www.pda.org/global-event-calendar/event-detail/joint-regulatory-conference-2026) |
| 2 | Veeva R&D and Quality Summit, U.S. 2026 | Oct. 20–21, 2026, Boston | HIGH | Private meetings + partner/customer-side intro, not public booth | No public CFP found; 100+ customer speakers means non-customer founder speaking is unlikely. | 2,500+ life-sciences attendees across quality, regulatory, safety, IT, and Vault platform; high concentration of QMS buyers. | [Veeva](https://www.veeva.com/events/rd-summit/) |
| 3 | ET Pharma Tech Conclave 2026 | July 24, 2026, Hyderabad | HIGH | Speaker/panel pitch immediately; private dinners with Hyderabad pharma IT/QA leaders | No CFP found; outreach now to ETPharma editorial/program team. | India AI-in-pharma event with 200+ attendees, 25+ speakers, AI operations/manufacturing content, and Hyderabad location. | [ETPharma](https://pharma.economictimes.indiatimes.com/tech-conclave) |
| 4 | iPHEX 2026 | Sept. 7–9, 2026, Bharat Mandapam, New Delhi | HIGH | Private-meeting route via Pharmexcil/exporter network; no booth unless post-go-live | No CFP found; Pharmexcil circular says more details will follow. | India pharma exporters, manufacturers, and procurement delegations; strong for Schedule M + export-quality positioning. | [Pharmexcil](https://pharmexcil.com/circulars/iphex-2026-%E2%80%93-september-7-9-2026/13972/79ef9e2ac422a96fc01f3d1d271f232a.html) |
| 5 | FDLI Annual Conference 2027 | May 5–6, 2027, Washington, DC + virtual | HIGH | Submit CFP for “FDA AI/ML guidance meets GxP validation” | CFP opens Aug. 17, 2026. | FDA-regulated legal/compliance audience; ideal for thought leadership on AI governance, validation evidence, and enforcement defensibility. | [FDLI](https://www.fdli.org/2027/05/2027-fdli-annual-conference/) |
| 6 | INTERPHEX 2027 | Apr. 13–15, 2027, Javits Center, New York | HIGH | Speaker/panel + private meetings; booth only if post-Sept go-live proves traction | CFP not found. | Manufacturing, biotechnology, expert-led conference, and pharma technology audience; strong CSV/CSA/QMS fit. | [INTERPHEX](https://www.interphex.com/en-us/show-info.html) |
| 7 | CPHI Americas 2027 | May 25–26, 2027, Miami Beach Convention Center | HIGH | Private meetings with CDMOs/API/formulation companies | CFP not found. | 3,700 attendee / 295 exhibitor scale; CDMO, manufacturing excellence, supply-chain, and strategic-partnership audience. | [CPHI Americas](https://www.cphi.com/americas/) |
| 8 | KENX AI in GxP / validation webinar series | Aug. 12, Sept. 9, Oct. 14, Nov. 11, 2026, online | HIGH | Co-webinar or guest expert pitch | Webinar topics already scheduled; pitch ASAP. | Directly names Annex 11/22, AI governance, cloud/hybrid GxP validation, and documentation evidence. | [KENX](https://kenx.org/webinars/) |
| 9 | AIPM Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine 2026 | Oct. 13–14, 2026, UC Berkeley | MEDIUM-HIGH | Poster + private meetings with sponsor pharma data/regulatory teams | Poster abstract deadline June 30, 2026. | Pharma-sponsored AI symposium with Amgen, Genentech, Novo Nordisk, Pfizer, ASA, and UC Berkeley; strong AI credibility, weaker QA buyer density. | [AIPM / ASA](https://ww2.amstat.org/meetings/aipm/2026/) |
| 10 | PharmaLab Congress 2026 | Nov. 23–25, 2026, Darmstadt, Germany | MEDIUM-HIGH | Private meetings; late speaker request only if agenda has gaps | Speaker submission deadline March 31, 2026, passed. | European GMP/QC/lab compliance event with AI in labs, data integrity, analytics, QC, and 600-colleague scale reported by media. | [PharmaLab](https://www.pharmalab-congress.com) |
| 11 | BIO-Europe 2026 | Nov. 9–11, 2026, Cologne, Germany | MEDIUM-HIGH | Private meeting model only | Presenting-company options; no Verixa-specific CFP found. | 5,000+ attendee partnering event with 25,000 one-to-one meetings; useful for EU biotech/pharma BD, less QA-focused. | [Trade Commissioner Service](https://www.tradecommissioner.gc.ca/en/trade-events-training/2026/11/bio-europe.html) |
| 12 | MasterControl Masters Summit 2026 | Oct. 12–15, 2026, Salt Lake City | MEDIUM | Attend/private meetings if QMS buyer access possible; avoid competitor-stage signaling | Speaker deadline May 29, 2026, likely passed. | 600+ attendees, 90+ speakers, 100+ sessions for quality and manufacturing professionals; vendor-owned audience creates access friction. | [MasterControl](https://www.mastercontrol.com/events/summit/2026/home/) |
| 13 | Bio-IT World Conference & Expo 2027 | May 18–20, 2027, Boston | MEDIUM | Panel pitch in AI/data governance track; private meetings | 2027 CFP not found; monitor CHI/CII calls. | Life-sciences IT and AI audience, useful for US AI governance credibility, but R&D/data-heavy rather than QA-heavy. | [Bio-IT World](https://www.bio-itworldexpo.com) |
| 14 | Bengaluru Tech Summit 2026 | Nov. 17–19, 2026, BIEC Bengaluru | MEDIUM | Healthtech/life-sciences AI panel pitch | No CFP found. | 600+ speakers, 100+ sessions, healthtech/life-sciences and AI tracks; good India visibility, but broader tech audience. | [Bengaluru Tech Summit](https://www.bengalurutechsummit.com/conference.php) |
| 15 | Global Digital Health Summit 2026 | Nov. 20–21, 2026, Bharat Mandapam, New Delhi | MEDIUM | AI governance panel / scientific paper if invited | Scientific papers invited; deadline not found. | “AI in Action” healthcare summit with pharma leaders and digital-health regulators; fit is adjacent rather than pharma-QMS-specific. | [GDHS](https://www.globalsummit.health) |
| 16 | EDQM–USP International Symposium on Pharmaceutical Reference Standards | Sept. 23–24, 2026, Strasbourg + online | MEDIUM | Attend for regulatory intelligence; unlikely founder speaking | Invitation/program route, no public CFP found. | Medicine-quality standards audience and online access; strong regulatory credibility, weaker AI/QMS buyer density. | [EDQM](https://www.edqm.eu/en/irss-event) |
| 17 | Frontiers Health 2026 | Oct. 20–21, 2026, Berlin | SPECULATIVE | Digital-health AI panel only if regulation/quality angle accepted | No CFP found. | Digital health and life-sciences innovation audience; broad, payer/provider-heavy, and less manufacturing-QA specific. | [Frontiers Health](https://www.frontiers.health/events) |
| 18 | CII Pharma & Life Sciences Summit 2026 | Sept. 18, 2026, Central Delhi | SPECULATIVE-MEDIUM | Policy roundtable/private intro via CII | No CFP found. | Potential India policy/industry access; limited public detail found beyond date and location. | [CII listing](https://uat.cii.in/Events.aspx?enc=5Qj31akIlo6Y7nuU38ndAv%2FIbK76huRyX4VXJ%2Fia5ebPq8Md6O3BrsAQoyTxYrTSBkvGGAKRB37+0S0FQG+BsQ%3D%3D) |

## Highest-priority recommendations

### 1) PDA/FDA Joint Regulatory Conference 2026 — best U.S. regulatory fit
- **Organizer:** Parenteral Drug Association and FDA.
- **Date/location:** Sept. 14–16, 2026, Washington, DC.
- **Audience:** Global regulators and pharma industry professionals; the event is positioned as a long-running trusted forum for regulator–industry dialogue.
- **Why high ROI for Verixa:** The agenda directly overlaps with Verixa’s validation and QMS thesis: pharmaceutical quality systems, ICH Q10, CAPA, QRM, data governance, CGMP, and AI in regulatory oversight.
- **Recommended posture:** Request private meetings with FDA-adjacent consultants, quality leaders, and PDA committee members; pitch a narrow panel contribution on “AI inspection readiness evidence packs under FDA AI/ML and GxP expectations.”
- **CFP/abstract deadline:** Not found; agenda appears active with named FDA and industry speakers.
- **Not already on Verixa list:** The tracked U.S. list includes PDA Annual 2027 and PDA chapters, but not the PDA/FDA Joint Regulatory Conference.
- **Source:** [PDA/FDA Joint Regulatory Conference 2026](https://www.pda.org/global-event-calendar/event-detail/joint-regulatory-conference-2026)

### 2) Veeva R&D and Quality Summit, U.S. 2026 — best QMS buyer concentration, but speaker access constrained
- **Organizer:** Veeva.
- **Date/location:** Oct. 20–21, 2026, Boston.
- **Audience:** 2,500+ life-sciences attendees and 250+ life-sciences companies across clinical, regulatory, safety, quality, training, and IT.
- **Why high ROI for Verixa:** Vault Quality, QA/QC, training, regulatory, safety, platform AI, and automation tracks align with Verixa’s QA/RA/IT ICP.
- **Recommended posture:** Use private meetings, customer-intro strategy, partner ecosystem conversations, and targeted “Annex 22 readiness” messaging; avoid booth posture.
- **CFP/abstract deadline:** No public CFP found.
- **Is it open to non-Veeva speakers?** Evidence suggests “mostly no” for a startup founder unless invited through a customer/partner path; Veeva emphasizes 100+ customer speakers and customer-led content.
- **Not already on Verixa list:** Vendor QMS summit not in tracked webinars/events list.
- **Source:** [Veeva R&D and Quality Summit U.S.](https://www.veeva.com/events/rd-summit/)

### 3) ET Pharma Tech Conclave 2026 — best immediate India AI-pharma opportunity
- **Organizer:** ETPharma / The Economic Times.
- **Date/location:** July 24, 2026, Hyderabad.
- **Audience:** 200+ attendees, 25+ speakers, 6+ sessions, and 8+ hours of networking.
- **Why high ROI for Verixa:** Hyderabad is dense with Indian pharma and CDMO decision-makers, and the program covers AI, data science, AI-led operations, manufacturing, and digital transformation.
- **Recommended posture:** Immediate speaker/panel pitch around “AI in GMP: from Schedule M readiness to Annex 22 validation evidence,” plus curated founder dinners with QA/IT heads.
- **CFP/abstract deadline:** Not found.
- **Not already on Verixa list:** Distinct from the already tracked Pharma IT Summit India and GPACTS series.
- **Source:** [ETPharma Tech Conclave](https://pharma.economictimes.indiatimes.com/tech-conclave)

### 4) iPHEX 2026 — best India exporter/CDMO private-meeting platform
- **Organizer:** Pharmexcil, supported by India’s Department of Commerce.
- **Date/location:** Sept. 7–9, 2026, Bharat Mandapam, New Delhi.
- **Audience:** International exhibition covering halls 1–5 and 5FF, with pharma and healthcare industry participation.
- **Why high ROI for Verixa:** Export-focused Indian manufacturers face Schedule M, WHO-GMP, EU, and U.S. quality expectations, making AI-assisted QMS evidence and CSV/CSA positioning relevant.
- **Recommended posture:** Private meetings through Pharmexcil and exporter associations; no booth before post-Sept go-live proof.
- **CFP/abstract deadline:** Not found; Pharmexcil says more details will be shared.
- **IPhEX 2027 status:** No official 2027 date was found; 2026 is the active official target-window edition.
- **Not already on Verixa list:** User specifically requested IPhEX; it was not in the tracked India list.
- **Source:** [Pharmexcil iPHEX circular](https://pharmexcil.com/circulars/iphex-2026-%E2%80%93-september-7-9-2026/13972/79ef9e2ac422a96fc01f3d1d271f232a.html)

### 5) FDLI Annual Conference 2027 — best CFP opportunity for FDA AI/ML compliance thought leadership
- **Organizer:** Food and Drug Law Institute.
- **Date/location:** May 5–6, 2027, Washington, DC + virtual.
- **Audience:** FDA-regulated industry, federal government, private bar, patient advocacy, consulting, and academia.
- **Why high ROI for Verixa:** Verixa can own a precise regulatory-technology topic: “validated AI evidence for FDA-regulated pharma QMS and quality systems.”
- **Recommended posture:** Submit CFP when it opens; ideal format is panel with FDA counsel, pharma QA leader, and validation expert.
- **CFP/abstract deadline:** CFP opens Aug. 17, 2026.
- **Not already on Verixa list:** FDLI was not in the tracked U.S. event list.
- **Source:** [FDLI Annual Conference 2027](https://www.fdli.org/2027/05/2027-fdli-annual-conference/)

## India — overlooked high-ROI events

| Event | Organizer | Date/window | Location | Audience size estimate | Verixa fit | Recommended posture | CFP/deadline | ROI tier | Gap filled | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| ET Pharma Tech Conclave 2026 | ETPharma / Economic Times | July 24, 2026 | Hyderabad | 200+ attendees, 25+ speakers | AI, data science, AI-led pharma operations, and manufacturing digital transformation. | Speaker/panel immediately + private Hyderabad meetings. | Not found. | HIGH | Pharma AI and manufacturing IT event not already tracked. | [ETPharma](https://pharma.economictimes.indiatimes.com/tech-conclave) |
| iPHEX 2026 | Pharmexcil | Sept. 7–9, 2026 | Bharat Mandapam, New Delhi | Multi-hall international exhibition | Exporter/CDMO/API/formulation audience needing global GMP evidence. | Private meetings through Pharmexcil/exporter network. | Not found. | HIGH | IPhEX requested by user and missing from existing list. | [Pharmexcil](https://pharmexcil.com/circulars/iphex-2026-%E2%80%93-september-7-9-2026/13972/79ef9e2ac422a96fc01f3d1d271f232a.html) |
| Bengaluru Tech Summit 2026 | Government of Karnataka | Nov. 17–19, 2026 | BIEC Bengaluru | 600+ speakers, 100+ sessions | Broad AI/healthtech/life-sciences platform; useful for India AI credibility and Bangalore GCC/biotech contacts. | Healthtech/life-sciences AI panel, not booth. | Not found. | MEDIUM | Non-ISPE, non-pharma-only India AI/life-sciences tech event. | [BTS conference](https://www.bengalurutechsummit.com/conference.php) |
| Global Digital Health Summit 2026 | Academy of Digital Health Sciences / GDHS | Nov. 20–21, 2026 | Bharat Mandapam, New Delhi | Global digital-health audience | “AI in Action” agenda and papers; includes pharma/digital-health leaders but broader than QMS. | AI governance panel or paper. | Papers invited; deadline not found. | MEDIUM | India digital-health AI event outside pharma trade-show circuit. | [GDHS](https://www.globalsummit.health) |
| 8th CII Pharma & Life Sciences Summit 2026 | CII | Sept. 18, 2026 | Central Delhi | Not found | Potential policy and industry access; limited public detail. | Policy roundtable/private intro. | Not found. | SPECULATIVE-MEDIUM | CII pharma/life-sciences channel requested by user. | [CII listing](https://uat.cii.in/Events.aspx?enc=5Qj31akIlo6Y7nuU38ndAv%2FIbK76huRyX4VXJ%2Fia5ebPq8Md6O3BrsAQoyTxYrTSBkvGGAKRB37+0S0FQG+BsQ%3D%3D) |
| Global Pharma Regulatory Summit, 14th Edition | CPHI Conferences / Informa Markets India | 2026 date not found | India | Not found | Specialized generics/biosimilars regulatory operations and submissions audience. | Contact content lead directly; page lists content/speaking contact. | Date not found. | SPECULATIVE | India regulatory-operations event not in existing tracker. | [GPRS](https://imconferences.com/gprs) |

### India-specific NASSCOM / healthcare-pharma AI answer
No pharma-specific NASSCOM healthcare AI event in the July 2026–July 2027 window was verified. The closest hits were broader NASSCOM/IndiaAI/GCC AI activity and India AI Impact Summit references that appear outside the target window or too broad for QA/RA buyer access. Recommendation: monitor NASSCOM AI, GCC, and healthcare vertical calendars quarterly, but do not prioritize until a pharma, life-sciences, regulated-AI, or healthcare compliance track is confirmed.

## U.S. — overlooked high-ROI events

| Event | Organizer | Date/window | Location | Audience size estimate | Verixa fit | Recommended posture | CFP/deadline | ROI tier | Gap filled | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| PDA/FDA Joint Regulatory Conference 2026 | PDA + FDA | Sept. 14–16, 2026 | Washington, DC | Global regulators and pharma industry professionals | FDA/GMP/PQS/data governance and AI oversight content. | Private meetings + late panel pitch. | Not found. | HIGH | FDA-adjacent PDA event missing from tracker. | [PDA](https://www.pda.org/global-event-calendar/event-detail/joint-regulatory-conference-2026) |
| FDLI Enforcement, Litigation, and Compliance Conference 2026 | FDLI | Dec. 10–11, 2026 | Washington, DC + virtual | Industry, FDA/DOJ/government, law firms | Compliance/enforcement defensibility; useful for AI validation risk narratives. | Private meetings; possible CFP path. | Notifications in Aug. 2026. | MEDIUM-HIGH | FDA enforcement forum not in tracker. | [FDLI](https://www.fdli.org/2026/12/2026-enforcement-litigation-and-compliance-conference-for-the-drug-device-food-and-tobacco-industries/) |
| FDLI Annual Conference 2027 | FDLI | May 5–6, 2027 | Washington, DC + virtual | 100+ officials/experts expected | Best CFP-led FDA AI/ML guidance compliance forum. | Submit CFP. | CFP opens Aug. 17, 2026. | HIGH | FDA food/drug law forum not in tracker. | [FDLI](https://www.fdli.org/2027/05/2027-fdli-annual-conference/) |
| AIPM Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine | ASA + Amgen, Genentech, Northeastern, Novo Nordisk, Pfizer, UC Berkeley | Oct. 13–14, 2026 | UC Berkeley | Pharma statisticians, data scientists, regulators, academia | AI governance credibility; less QA-heavy. | Poster + targeted sponsor meetings. | Poster abstract deadline June 30, 2026. | MEDIUM-HIGH | Pharma AI forum outside ISPE/DIA/RAPS. | [AIPM](https://ww2.amstat.org/meetings/aipm/2026/) |
| INTERPHEX 2027 | RX | Apr. 13–15, 2027 | Javits Center, New York | Large pharma/biotech manufacturing expo | Manufacturing, technology, QMS, automation, validation. | Speaker/panel + private meetings; booth only after traction. | Not found. | HIGH | Manufacturing technology event not in tracker. | [INTERPHEX](https://www.interphex.com/en-us/show-info.html) |
| CPHI Americas 2027 | Informa Markets | May 25–26, 2027 | Miami Beach Convention Center | 3,700 attendees, 295 exhibitors, 16 start-ups | CDMO/API/formulation ecosystem and partnerships. | Private meeting model. | Not found. | HIGH | North America CPHI/CDMO event missing from tracker. | [CPHI Americas](https://www.cphi.com/americas/) |
| Bio-IT World Conference & Expo 2027 | Cambridge Innovation Institute | May 18–20, 2027 | Boston | 2026 event cited 2,900+ leaders in biopharma, biomedical research, healthcare, informatics, and technology | AI/data/IT credibility; not primarily QA/RA. | AI/data governance panel. | 2027 CFP not found. | MEDIUM | CHI/Cambridge Healthtech IT event requested by user. | [Bio-IT World](https://www.bio-itworldexpo.com) |
| HLTH USA 2026 | HLTH | Nov. 15–18, 2026 | Venetian Expo, Las Vegas | 12,250+ attendees, 4,400+ C-suite, 8,500+ meetings | Massive healthcare AI audience, but not pharma-QMS-specific. | Only if a pharma AI compliance dinner can be piggybacked. | Not found. | SPECULATIVE | Digital-health mega-event requested by user. | [HLTH](https://hlth.com/events/usa/) |
| HIMSS27 | HIMSS | Apr. 5–8, 2027 | McCormick Place, Chicago | HIMSS26 drew 24,000; HIMSS27 scheduled in Chicago | Healthcare IT audience; weak pharma manufacturing/QA density. | Do not prioritize unless partnered with life-sciences IT buyer. | Not found. | SPECULATIVE | Digital-health IT event requested by user. | [HIMSS](https://www.himssconference.com/about-the-conference/) |

### AAPS PharmSci 360 2026 fit assessment
AAPS PharmSci 360 2026 is a **MEDIUM-to-LOW fit** for Verixa because the event is strong for pharmaceutical sciences and R&D but weaker for QA/RA/IT decision-makers. The 2026 event runs Oct. 25–28 in New Orleans, and future AAPS dates include Nov. 13–17, 2027 in Anaheim. The programming route is also timing-constrained: the session proposal deadline was April 8, 2026 and the rapid-fire deadline was June 12, 2026. Verixa should not prioritize AAPS unless it can package a scientifically rigorous “validated AI model governance in drug development submissions” poster or meet pharma data-science/regulatory teams privately. Sources: [AAPS future events](https://www.aaps.org/pharmsci/future-annual-events), [AAPS programming](https://www.aaps.org/pharmsci/ps360submit)

### INTERPHEX 2027 fit assessment
INTERPHEX 2027 is a **HIGH fit** after Verixa’s September 2026 go-live decision because it directly targets pharma and biotech manufacturing, technology, and expert-led education. The official show page lists Apr. 13–15, 2027 at Javits Center, New York. Best Verixa angle: “AI validation evidence for GMP manufacturing systems and eQMS workflows.” Source: [INTERPHEX](https://www.interphex.com/en-us/show-info.html)

### CPhI North America / CPHI Americas 2027 fit assessment
CPhI North America has effectively become **CPHI Americas 2027**, and it is a **HIGH fit for private meetings** rather than a booth-first strategy. The official page lists May 25–26, 2027 at Miami Beach Convention Center and cites 2026 metrics of about 3,700 attendees, 295 exhibitors, and 16 start-ups. Best Verixa angle: Indian/CDMO quality digitization for U.S. market access and FDA AI/ML guidance readiness. Source: [CPHI Americas](https://www.cphi.com/americas/)

## EU — overlooked high-ROI events

| Event | Organizer | Date/window | Location | Audience size estimate | Verixa fit | Recommended posture | CFP/deadline | ROI tier | Gap filled | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| PharmaLab Congress 2026 | Concept Heidelberg / PharmaLab | Nov. 23–25, 2026 | Darmstadt, Germany | Around 600 colleagues reported by media | AI in laboratories, GMP compliance, QC, data integrity. | Private meetings; late session pitch only if gaps. | Speaker deadline March 31, 2026, passed. | MEDIUM-HIGH | EU GMP/QC/lab AI event not in tracker. | [PharmaLab](https://www.pharmalab-congress.com) |
| EDQM–USP International Symposium on Pharmaceutical Reference Standards | EDQM + USP | Sept. 23–24, 2026 | Strasbourg + online | Global industry, regulators, academia | Medicine-quality standards and regulatory science; adjacent to QMS. | Attend/virtual for regulatory intelligence. | Not found. | MEDIUM | EMA/quality-adjacent standards forum. | [EDQM](https://www.edqm.eu/en/irss-event) |
| BIO-Europe 2026 | Informa Connect / EBD | Nov. 9–11, 2026 | Cologne, Germany | 5,000+ attendees, 3,000 companies, 25,000 one-to-one meetings | Private meetings with EU biotech/pharma; less QA-specific. | PartneringONE meetings only. | Not found. | MEDIUM-HIGH | EU private-meeting model not on tracker. | [Trade Commissioner Service](https://www.tradecommissioner.gc.ca/en/trade-events-training/2026/11/bio-europe.html) |
| BIO-Europe Spring 2027 | EBD Group + Lyon partners | Apr. 5–7, 2027 | Eurexpo Lyon, France | Major European biotech/healthcare gathering | Partnering with biotech/pharma; less QA-specific. | Partnering meetings. | Not found. | MEDIUM | 2027 curated partnering route. | [ONLYLYON](https://invest.onlylyon.com/en/actualites/lyon-to-host-bio-europe-spring-2027/) |
| Frontiers Health 2026 | Frontiers Health | Oct. 20–21, 2026 | Berlin | Digital health leaders/innovators | Digital-health AI and innovation; broad, not pharma-QMS. | Panel only if AI governance/compliance theme. | Not found. | SPECULATIVE | EU digital-health event requested by user. | [Frontiers Health](https://www.frontiers.health/events) |
| Reuters Events Pharma 2027 | Reuters Events | Apr. 22–24, 2027 | Europe; venue not fully captured in search | Senior cross-functional pharma leaders | Broad commercial/medical/data event; AI scaling and EU regulatory environment themes. | Executive panel only if pharma AI operating model accepted. | Not found. | SPECULATIVE-MEDIUM | Non-ISPE European pharma leadership event. | [Reuters Events](https://events.reutersevents.com/pharma/pharma-europe) |
| PHARMAP 2027 | BGS Group / PHARMAP | 2027 date not fully captured | Europe | Closed-door manufacturing/packaging congress | Digital Pharma 4.0, AI/ML, digital twins, smart operations. | Private meetings; monitor 2027 agenda. | Not found. | SPECULATIVE-MEDIUM | Non-ISPE Pharma 4.0/manufacturing event. | [PHARMAP](https://pharmap-congress.com) |

## Global / online / vendor event opportunities

| Event / series | Organizer | Date/window | Location | Audience | Verixa fit | Posture | ROI tier | Source |
|---|---|---|---|---|---|---|---|---|
| Veeva R&D and Quality Summit U.S. 2026 | Veeva | Oct. 20–21, 2026 | Boston | 2,500+ life-sciences attendees, 250+ companies | Quality, regulatory, safety, platform AI, QA/QC, training. | Private meetings; speaker only via customer/partner path. | HIGH | [Veeva U.S.](https://www.veeva.com/events/rd-summit/) |
| Veeva R&D and Quality Summit Europe 2027 | Veeva | May 20–21, 2027 | Copenhagen | Life-sciences sponsors/CROs/sites; quality, regulatory, safety and Vault platform | “Agentic Biopharma,” AI agents, QA/QC, regulatory and training workflows. | Customer/partner intro + private meetings. | HIGH | [Veeva Europe](https://www.veeva.com/eu/events/rd-summit/overview/) |
| MasterControl Masters Summit 2026 | MasterControl | Oct. 12–15, 2026 | Salt Lake City | 600+ attendees, 90+ speakers, 100+ sessions | Quality/manufacturing professionals; strong QMS buyer context. | Private meetings only; speaker deadline passed. | MEDIUM | [MasterControl](https://www.mastercontrol.com/events/summit/2026/home/) |
| KENX AI in GxP webinar series | KENX | Aug.–Nov. 2026 | Online | GxP validation, QA, IT, regulatory professionals | Annex 11/22, AI governance, cloud/hybrid GxP validation, evidence/documentation. | Co-webinar pitch; guest subject-matter expert. | HIGH | [KENX webinars](https://kenx.org/webinars/) |
| ComplianceOnline FDA Regulation of AI & ML | ComplianceOnline | On-demand / date not clearly listed | Online | Quality systems and manufacturing leadership | FDA AI/ML regulatory education; good for competitive/topic scan. | Do not prioritize as speaker; use for lead-magnet topic benchmarking. | SPECULATIVE | [ComplianceOnline](https://www.complianceonline.com/fda-regulation-of-artificial-intelligence-machine-learning-webinar-training-706954-prdw) |
| Honeywell / Sparta TrackWise events | Honeywell / Sparta Systems | No target-window user conference verified | Various / online | TrackWise/eQMS users | Very relevant audience, but public TrackWise user event date was not verified in target window. | Monitor; seek partner intro if a TUG is announced. | SPECULATIVE | [Honeywell events archive](https://www.spartasystems.com/resource_type/event/) |

## Answers to specific research questions

### Is AAPS PharmSci 360 2026 a good fit?
**Only a selective fit.** The event is credible and large, but the buyer mix is more pharmaceutical science, formulation, discovery, modeling, and translational research than QA/RA/IT QMS ownership. The 2026 event is Oct. 25–28 in New Orleans, and the best Verixa use case is a poster/private-meeting route on validated AI evidence in regulated development submissions. Sources: [AAPS future events](https://www.aaps.org/pharmsci/future-annual-events), [AAPS programming](https://www.aaps.org/pharmsci/ps360submit)

### Is INTERPHEX 2027 a good fit?
**Yes — high fit.** INTERPHEX 2027 is a strong manufacturing-technology and biotech/pharma operations forum after Verixa’s September go-live decision. Prioritize speaker/panel and private meetings, not booth-first spend. Source: [INTERPHEX](https://www.interphex.com/en-us/show-info.html)

### Is CPhI North America 2027 a good fit?
**Yes — under the updated CPHI Americas branding.** The Miami 2027 event is strong for CDMO, manufacturing, outsourcing, and strategic partnerships, making it useful for Verixa’s Indian CDMO and U.S. compliance bridge positioning. Source: [CPHI Americas](https://www.cphi.com/americas/)

### Any India-specific NASSCOM healthcare/pharma AI events for 2026–2027?
No pharma-specific NASSCOM healthcare AI event was verified in the target window. The related evidence points to broad AI/GCC activity, not a confirmed pharma-QMS or healthcare-regulatory buyer event. Keep NASSCOM as a monitor-only channel unless a life-sciences, regulated-AI, healthcare compliance, or pharma GCC agenda appears.

### Any Pharma 4.0 / Industry 4.0 pharma events not ISPE-organized?
Yes. PHARMAP 2027 appears to be the most relevant non-ISPE European manufacturing option because its public agenda language includes Digital Pharma 4.0, digital twins, AI/ML, data integration, and next-generation facilities. BTS and ETPharma also provide non-ISPE India AI/manufacturing-tech angles. Sources: [PHARMAP](https://pharmap-congress.com), [BTS](https://www.bengalurutechsummit.com/conference.php), [ETPharma](https://pharma.economictimes.indiatimes.com/tech-conclave)

### Is Veeva Vault Quality Summit open to non-Veeva speakers?
No public evidence of an open speaker CFP was found. The U.S. summit emphasizes 100+ customer speakers, and the Europe summit speaker pages show industry/customer leaders from companies using or operating around Veeva ecosystems. Verixa should pursue a customer/partner-mediated route rather than expect a standard external-founder CFP. Sources: [Veeva U.S.](https://www.veeva.com/events/rd-summit/), [Veeva Europe speakers](https://www.veeva.com/eu/events/rd-summit/speakers/)

## Action plan for Verixa

| Timing | Action | Target events |
|---|---|---|
| Now–June 30, 2026 | Submit AIPM poster if relevant and outreach ETPharma for July 24 panel slot. | AIPM, ET Pharma Tech Conclave |
| July 2026 | Run India thought-leadership sprint: “Schedule M + AI governance + Annex 22 readiness.” | ETPharma, iPHEX, CII |
| Aug. 2026 | Submit FDLI Annual 2027 CFP; pitch KENX webinar collaboration. | FDLI, KENX |
| Sept.–Oct. 2026 | Use no-booth private-meeting posture at PDA/FDA, iPHEX, Veeva, AIPM. | PDA/FDA, iPHEX, Veeva, AIPM |
| Nov. 2026 | EU intelligence and BD sprint. | BIO-Europe, PharmaLab, Frontiers Health |
| Jan.–Apr. 2027 | Push U.S. manufacturing/validation messaging. | INTERPHEX, FDLI, HIMSS only if partnered |
| May–July 2027 | Run CDMO + QMS private-meeting campaign. | CPHI Americas, Veeva Europe, Bio-IT World |